DOI,title,author,year,times_seen
10.1093/jac/dkx093,Dose optimization of piperacillin/tazobactam in critically ill children,De Cock,2017,6
10.1007/s40272-014-0093-1,Optimized Antimicrobial Dosing Strategies: A Survey of Pediatric Hospitals,Knoderer,2014,1
10.1097/cce.0000000000000446,Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?,Barreto,2021,7
10.1128/cmr.00007-10,Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections,Nau,2010,1
10.1097/inf.0000000000002663,Paradoxical Antibiotic Effect of Ampicillin,Ericson,2020,5
10.1128/aac.36.3.540,Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis,Snydman,2012,2
10.1016/j.ijantimicag.2018.10.004,Quantifying the importance of active antimicrobial therapy among patients with Gram-negative bloodstream infections: Cefepime as a representative agent,Miglis,2018,1
10.1128/jcm.41.8.3655-3660.2003,Epidemiology and Outcome of Nosocomial and Community-Onset Bloodstream Infection,Diekema,2003,1
10.1007/s40262-017-0602-9,Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children,Béranger,2017,5
10.1097/pcc.0000000000000847,Epidemiology of Sepsis in Children Admitted to PICUs in South America*,de Souza,2016,4
10.1097/pcc.0000000000000254,Pediatric Severe Sepsis,Ruth,2014,1
10.1097/00003246-200107000-00002,"Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care",Angus,2003,3
10.1007/s001340050041,Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome,Wichmann,2002,1
10.1186/s13054-017-1829-4,Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study,Ehmann,2017,1
10.1186/s13054-015-0818-8,A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics,Roberts,2015,1
10.2165/00003088-200746120-00003,Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy,Pea,2009,1
10.1177/0091270005280583,Meropenem and Continuous Renal Replacement Therapy: In Vitro Permeability of 2 Continuous Renal Replacement Therapy Membranes and Influence of Patient Renal Function on the Pharmacokinetics in Critically Ill Patients,Isla,2005,1
10.1016/s0272-6386(99)70076-4,Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates,Brunet,2008,1
10.1016/s0272-6386(97)90536-9,The role of renal replacement therapy quantification in acute renal failure,Clark,2008,1
10.1016/s0272-6386(12)80984-x,Urea Index and Other Predictors of Hemodialysis Patient Survival,Collins,2014,1
10.1016/s0272-6386(12)70354-2,"Proceedings From the Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, TX, September 15 to 17, 1989",Hull,2014,1
10.1093/cid/ciu027,DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?,Roberts,2014,9
10.2165/11318140-000000000-00000,Augmented Renal Clearance,Udy,2009,3
10.1378/chest.118.1.146,The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting,Ibrahim,2003,1
10.1086/520311,Vancomycin‐Resistant and Vancomycin‐Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes,Lucas,2007,1
10.1086/313692,National Survey of Extended-Interval Aminoglycoside Dosing,Chuck,2002,1
10.1093/clinids/24.5.820,Editorial Response: Single Daily Dosing of Aminoglycosides--A Concept Whose Time Has Not Yet Come,Bertino,2011,1
10.1128/aac.00654-17,Neurotoxic Concentration of Piperacillin during Continuous Infusion in Critically Ill Patients,Quinton,2017,4
10.1007/s10096-005-0021-y,Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside,Chow,2005,3
10.1007/s00134-001-1170-9,Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure,Chatellier,2003,1
10.1128/aac.00144-06,"β-Lactam MICs Correlate Poorly with Mutant Prevention Concentrations for Clinical Isolates of
            <i>Acinetobacter</i>
            spp. and
            <i>Pseudomonas aeruginosa</i>",Gugel,2006,1
10.1016/s0732-8893(99)00121-2,Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America,Gales,2002,1
10.1093/jac/29.3.349,The emergence of highly fluoroquinolone-resistant <i>Eschericha coli</i> in community-acqntred urinary tract infections,AGUIAR,2007,2
10.1001/jama.2009.1754,International Study of the Prevalence and Outcomes of Infection in Intensive Care Units,Vincent,2009,3
10.1016/j.diagmicrobio.2015.03.005,Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC,Rhodes,2015,2
10.1086/510590,Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy,Lodise,2007,1
10.1016/s1473-3099(19)30403-7,"Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial",Kollef,2019,5
10.1198/sbr.2009.0049,Stratified Wilson and Newcombe Confidence Intervals for Multiple Binomial Proportions,Yan,2009,1
10.1016/j.jspi.2003.09.039,Confidence intervals for two sample binomial distribution,Brown,2004,1
10.2307/2685779,Simple and Effective Confidence Intervals for Proportions and Differences of Proportions Result from Adding Two Successes and Two Failures,Agresti,2006,1
10.1073/pnas.94.25.13991,DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance,Zhao,2002,1
10.1128/aac.41.1.85,"A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics",Truong,2018,1
10.1007/s40264-017-0578-2,Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review,Deshayes,2017,1
10.1093/jac/6.2.161,Neurotoxicity of penicillin,NICHOLLS,2007,1
10.2165/00003495-200059030-00016,Meropenem,Hurst,2006,1
10.1016/s0924-8579(98)00094-6,Carbapenems in clinical practice: a guide to their use in serious infection,Bradley,2002,1
10.1007/bf00299113,Adjunctive antimicrobial therapy for complicated appendicitis: Bacterial overkill by combination therapy,Hopkins,2004,1
10.1097/00000658-199002000-00008,The Bacteriology of Gangrenous and Perforated Appendicitis—Revisited,BENNION,2006,1
10.1128/aac.01956-15,Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival,Rhodes,2015,2
10.1097/ftd.0b013e31825c4ba6,"Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R",Neely,2012,1
10.1097/00007691-200006000-00018,Achieving Target Goals Most Precisely Using Nonparametric Compartmental Models and “Multiple Model” Design of Dosage Regimens,Jelliffe,2003,2
10.1007/s10096-019-03535-w,Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis,Hartman,2019,5
10.5863/1551-6776-22.4.276,Population Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Critically Ill Young Children,Cies,2017,7
10.1128/aac.40.5.1139,Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation,Amaker,2018,1
10.1086/520195,Antimicrobial Resistance in Key Bloodstream Bacterial Isolates: Electronic Surveillance with The Surveillance Network Database‐‐USA,Sahm,2007,1
10.1097/00006454-199603000-00015,Pharmacokinetics and pharmacodynamics of antibiotics in otitis media,CRAIG,2003,1
10.1128/aac.36.4.856,"Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin",Spangler,2012,1
10.1007/s00134-013-3088-4,Clinical implications of antibiotic pharmacokinetic principles in the critically ill,Udy,2013,1
10.1186/cc10441,Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams,Gonçalves-Pereira,2011,1
10.1097/00003246-200207000-00013,Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis,Joukhadar,2003,1
10.1093/jac/31.suppl_d.1,Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans,Ryan,2012,1
10.2165/00019053-199610050-00007,The Economic Impact of Once-Daily versus Conventional Administration of Gentamicin and Tobramycin,Mithani,2009,1
10.1136/archdischild-2019-317342,Serum amoxicillin levels in young infants (0–59 days) with sepsis treated with oral amoxicillin,Mir,2020,5
10.1038/jp.2010.191,"Why do families of sick newborns accept hospital care? a community-based cohort study in Karachi, Pakistan",Owais,2011,1
10.1038/jp.2008.165,Care-seeking practices in South Asia: using formative research to design program interventions to save newborn lives,Syed,2008,1
10.1363/3307507,Maternal Health and Care-Seeking Behavior In Bangladesh: Findings from a National Survey,Koenig,2007,1
10.1016/j.ijantimicag.2007.12.009,Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T&gt;MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections,McKinnon,2008,4
10.5863/1551-6776-19.4.262,Developmental Pharmacokinetics in Pediatric Populations,Lu,2020,2
10.1345/aph.17228,Ampicillin-Induced Neurotoxicity in Very-Low-Birth-Weight Neonates,Shaffer,2004,1
10.1016/0887-8994(88)90011-2,Intraventricular nafcillin-induced seizures in a neonate,Brozanski,2003,2
10.1002/j.1552-4604.1974.tb01364.x,Neurotoxicity During Intravenous Infusion of Penicillin. A Review,FOSSIECK,2013,1
10.1016/s0022-5223(19)42095-3,Epilepsy in cardiopulmonary bypass patients receiving large intravenous doses of penicillin,Currie,2019,1
10.1128/aac.01368-15,Augmented Renal Clearance Implies a Need for Increased Amoxicillin-Clavulanic Acid Dosing in Critically Ill Children,De Cock,2015,4
10.1159/000180580,Prediction of Creatinine Clearance from Serum Creatinine,Cockcroft,2008,2
10.1097/ccm.0b013e31827e83af,Surviving Sepsis Campaign,Dellinger,2013,3
10.1007/s00134-008-1310-6,End-of-life practices in 282 intensive care units: data from the SAPS 3 database,Azoulay,2008,1
10.1378/chest.121.3.957,Do Specialists Differ on Do-Not-Resuscitate Decisions?,Kelly,2003,1
10.1001/jama.1988.03410060067029,Patients' and Families' Preferences for Medical Intensive Care,Danis,2011,1
10.1016/j.cmi.2018.11.020,Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study,Bricheux,2018,5
10.1016/j.ijantimicag.2014.12.017,"Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study",Huttner,2015,1
10.1093/jac/32.suppl_b.103,Pharmacokinetics of cefepime: a review,Van der Auwera,2012,1
10.1592/phco.26.9.1320,Application of Antimicrobial Pharmacodynamic Concepts into Clinical Practice: Focus on β-Lactam Antibiotics: Insights from the Society of Infectious Diseases Pharmacists,Lodise,2006,8
10.1128/aac.46.2.586-589.2002,Levofloxacin Penetration into Epithelial Lining Fluid as Determined by Population Pharmacokinetic Modeling and Monte Carlo Simulation,Drusano,2002,2
10.1128/aac.44.1.173-177.2000,"Activities of Masked 2′,3′-Dideoxynucleoside Monophosphate Derivatives against Human Immunodeficiency Virus in Resting Macrophages",Aquaro,2009,1
10.1177/095632029800900105,Synthesis and Antiviral Evaluation of SATE-Foscarnet Prodrugs and New Foscarnet—AZT Conjugates,Meier,2015,1
10.1177/095632029600700103,Intracellular Metabolism of 3′-Azido-3′-Deoxythymidine in the Presence of Ganciclovir or Foscarnet,Palmer,2015,1
10.1093/jac/dkt523,"An international, multicentre survey of  -lactam antibiotic therapeutic drug monitoring practice in intensive care units",Wong,2014,4
10.1016/j.ejps.2021.105868,Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis,Li,2021,6
10.1016/j.xphs.2021.02.001,Dosage Adjustment for Ceftazidime in Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic Modeling,Zhou,2021,1
10.1016/s2213-2600(18)30063-8,The global burden of paediatric and neonatal sepsis: a systematic review,Fleischmann-Struzek,2018,1
10.1157/13107391,Incidencia estimada y análisis de la sepsis en un área de Valencia,Bou Monterde,2007,1
10.1128/aac.01045-16,A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants,Leroux,2016,3
10.1093/infdis/jiy578,Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia,Talbot,2018,1
10.1097/ccm.0b013e3181691b99,"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*",Chastre,2009,1
10.1007/s001340000640,Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia,Dupont,2003,1
10.1172/jci107767,Inhibition of Penicillin Transport from the Cerebrospinal Fluid after Intracisternal Inoculation of Bacteria,Spector,2008,1
10.1128/aac.40.8.1881,Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus,Ng,2018,1
10.1016/s2214-109x(14)70347-x,"Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trial",Baqui,2015,1
10.1097/inf.0b013e31819069e8,Effectiveness of Home-Based Management of Newborn Infections by Community Health Workers in Rural Bangladesh,Baqui,2009,1
10.1016/j.trstmh.2005.11.004,Can community health workers and caretakers recognise pneumonia in children? Experiences from western Uganda,Källander,2006,1
10.1016/j.actatropica.2003.11.013,Symptom overlap for malaria and pneumonia—policy implications for home management strategies,Källander,2004,1
10.1046/j.1365-3156.2002.00827.x,Use of clinical algorithms for diagnosing malaria1,Chandramohan,2003,1
10.1016/0001-706x(93)90068-m,Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission,Smith,2002,1
10.1080/00034983.1954.11685599,The Recognition of Age-Groups within Populations of<i>Anopheles Gambiae</i>by the Pre-Gravid Rate and the Sporozoite Rate,Gillies,2016,1
10.1017/s0007485300023221,Studies on <i>Anopheles gambiae</i> and <i>A. melas</i> in and around Lagos,Thomson,2009,1
10.1080/00034983.1932.11684720,"A Study of the House-Haunting Culicidae Occurring in Freetown, Sierra Leone; and of the Part Played by them in the Transmission of Certain Tropical Diseases, Together with Observations on the Relationship of Anophelines to Housing, and the Effects of Antilarval Measures in Freetown",Gordon,2016,1
10.1080/00034983.1930.11684624,The Transmission of Malaria in Sierra Leone,Gordon,2016,1
10.1017/s000748530004637x,"The Seasonal Habit of the common Anophelines of Nyasaland, with a Note on its Relation to the Seasonal Incidence of Malaria",Lamborn,2009,1
10.5962/bhl.title.97575,"Report of the malaria expedition to the Gambia 1902, of the Liverpool School of Tropical Medicine and Medical Parasitology",Dutton,2015,1
10.1016/s0196-0644(83)80650-7,Psychotic-like reaction to procaine penicillin G,Lankin,2005,1
10.1093/cid/cis857,Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis,Falagas,2012,1
10.1016/j.ijantimicag.2006.02.020,Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients,Rafati,2006,1
10.1097/ccm.0b013e3181961bff,Pharmacokinetic issues for antibiotics in the critically ill patient,Roberts,2009,4
10.1007/s10156-003-0279-x,Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling,Nicolau,2004,1
10.1128/aac.44.12.3351-3356.2000,"Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756",Fung-Tomc,2002,1
10.1001/jama.279.2.125,Pharmacodynamics of Levofloxacin,Preston,2003,2
10.1186/cc13938,Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy,Ulldemolins,2014,6
10.1016/j.ijantimicag.2014.01.009,Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration,Varghese,2014,1
10.1093/jac/47.4.421,The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients,Joynt,2002,2
10.1128/aac.43.8.2051,"Comparative In Vitro Activities of Ciprofloxacin, Clinafloxacin, Gatifloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin against
            <i>Klebsiella pneumoniae</i>
            ,
            <i>Klebsiella oxytoca</i>
            ,
            <i>Enterobacter cloacae</i>
            , and
            <i>Enterobacter aerogenes</i>
            Clinical Isolates with Alterations in GyrA and ParC Proteins",Brisse,2018,1
10.1016/0732-8893(94)90033-7,Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?,Jones,2002,1
10.1016/0196-4399(94)90057-4,Detection of antimicrobial resistance in Streptococcus pneumoniae by use of standardized susceptibility testing methods and recently developed interpretive criteria,Jorgensen,2002,1
10.1097/00006454-199303000-00004,Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis,FRIEDLAND,2006,1
10.1517/17425255.2013.799137,"Drug absorption, distribution, metabolism and excretion considerations in critically ill adults",Roberts,2013,1
10.1128/aac.01318-06,"Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled Trial",Sakka,2007,1
10.2165/00003088-200847040-00002,Facilitation of Drug Evaluation in Children by Population Methods and Modelling†,Tod,2009,1
10.1097/mph.0b013e318047b79d,Clinical Pharmacology of Asparaginases in the United States: Asparaginase Population Pharmacokinetic and Pharmacodynamic (PK-PD) Models (NONMEM) in Adult and Pediatric ALL Patients,Avramis,2007,1
10.1182/blood.v96.5.1709,Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study,Abshire,2019,1
10.1182/blood.v81.3.602.602,Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study,Sadowitz,2019,1
10.1016/s1473-3099(03)00737-0,"Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials",Sazawal,2003,1
10.1086/515108,A National Program for Control of Acute Respiratory Tract Infections: The Philippine Experience,Dayrit,2007,1
10.1093/clinids/12.supplement_1.s9,In Vitro Antibacterial Activity of Bismuth Subsalicylate,Cornick,2011,1
10.1086/430906,Antimicrobial Resistance among<i>Streptococcus pneumoniae</i>in the United States: Have We Begun to Turn the Corner on Resistance to Certain Antimicrobial Classes?,Doern,2005,1
10.1056/nejm199907223410403,Decreased Susceptibility of<i>Streptococcus pneumoniae</i>to Fluoroquinolones in Canada,Chen,2002,1
10.1128/jcm.33.9.2233-2239.1995,Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing,Tenover,2020,1
10.1128/aac.02089-15,Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children,Nichols,2015,6
10.1016/j.ijantimicag.2005.06.004,Pharmacodynamics of intermittent and continuous infusion piperacillin/tazobactam and cefepime against extended-spectrum β-lactamase-producing organisms,Reese,2005,1
10.1128/aac.47.5.1643-1646.2003,"Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam against
            <i>Escherichia coli</i>
            and
            <i>Klebsiella pneumoniae</i>
            Strains Producing Extended-Spectrum β-Lactamases: Report from the ARREST Program",Ambrose,2003,1
10.1128/aac.45.1.13-22.2001,Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint,Drusano,2002,1
10.1016/s0732-8893(98)00105-9,"Antimicrobial activity of SCH27899 (Ziracin®), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/Etest method evaluations and quality control guidelines",Marshall,2002,1
10.1016/s0732-8893(98)00039-x,"Epidemiology, Laboratory Detection, and Therapy of Penicillin-resistant Streptococcal Infections",Jones,2002,1
10.1111/j.1574-6968.1991.tb05121.x,Relatedness between Streptococcus pneumoniae and viridans streptococci: transfer of penicillin resistance determinants and immunological similarities of penicillin-binding proteins,Chalkley,2006,1
10.1093/infdis/164.2.313,Antigenic Variation of Penicillin-Binding Proteins from Penicillin-Resistant Clinical Strains of Streptococcus pneumoniae,Hakenbeck,2011,1
10.1172/jci102149,MATURATION OF RENAL FUNCTION IN CHILDHOOD:  CLEARANCE STUDIES12,Rubin,2008,1
10.1164/ajrccm.155.1.9001282,Increasing incidence of withholding and withdrawal of life support from the critically ill.,Prendergast,2013,1
10.1093/infdis/jiaa118,Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review,Phe,2020,4
10.1007/s00134-017-4683-6,Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016,Rhodes,2017,1
10.1378/chest.11-1671,Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients,Udy,2011,4
10.1128/aac.47.6.1853-1861.2003,Pharmacokinetics and Pharmacodynamics of Cefepime in Patients with Various Degrees of Renal Function,Tam,2003,2
10.1128/aac.36.3.552,Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects,Barbhaiya,2012,1
10.2165/00003088-200039040-00003,Pharmacokinetics of Meropenem in Patients with Renal Failure and Patients Receiving Renal Replacement Therapy,Thalhammer,2006,1
10.1128/aac.42.9.2417,Single-Dose Pharmacokinetics of Meropenem during Continuous Venovenous Hemofiltration,Thalhammer,2018,1
10.1007/bf00314864,Pharmacokinetics of meropenem in subjects with renal insufficiency,Leroy,2004,1
10.1128/aac.33.4.562,"Multicenter in vitro evaluation of SM-7338, a new carbapenem",Jones,2012,1
10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e,Two-sided confidence intervals for the single proportion: comparison of seven methods,Newcombe,2002,1
10.1097/01.ftd.0000249946.20294.59,Population Pharmacokinetics and Dosing of Amoxicillin in (pre)term neonates,van den Anker,2006,1
10.1016/0009-9236(95)90021-7,Ceftazidime pharmacokinetics in preterm infants: Effects of renal function and gestational age*,van den Anker,2005,1
10.1097/00006454-199002000-00009,The use of antibiotics in neonates weighing less than 1200 grams,PROBER,2006,1
10.1111/j.1574-6968.1982.tb08625.x,Penicillin-binding proteins of nutritionally variant streptococci,Gutmann,2006,1
10.1128/aac.17.3.434,Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae,Zighelboim,2012,1
10.1016/0096-3003(91)90077-z,Nonparametric EM Algorithms for estimating prior distributions,Schumitzky,2002,2
10.1214/aos/1176349740,A Large Sample Study of Generalized Maximum Likelihood Estimators from Incomplete Data Via Self-Consistency,Tsai,2007,1
10.1002/phar.2505,A guide to therapeutic drug monitoring of β‐lactam antibiotics,Fratoni,2021,7
10.1007/s11695-011-0586-8,Cefepime Dosing in the Morbidly Obese Patient Population,Rich,2012,2
10.1186/s13054-017-1856-1,Cefepime-induced neurotoxicity: a systematic review,Payne,2017,6
10.1111/j.1445-5994.2012.02800.x,Cefepime: a rare cause of encephalopathy,McNally,2012,1
10.1016/j.ijid.2003.09.003,Cefepime-induced encephalopathy,Dakdouki,2003,1
10.1212/wnl.55.11.1756,Cerebral manifestations of cefepime toxicity in a dialysis patient,Fishbain,2012,2
10.1007/s11095-005-5641-5,Disease System Analysis: Basic Disease Progression Models in Degenerative Disease,Post,2005,1
10.1124/jpet.102.036798,Pharmacokinetic-Pharmacodynamic Modeling of Buspirone and Its Metabolite 1-(2-Pyrimidinyl)-piperazine in Rats,Zuideveld,2003,1
10.1016/0278-5846(89)90026-2,Chronic treatment with amitriptyline produces subsensitivity to the hypothermic effects of clonidine,Dilsaver,2002,1
10.1007/bf00517308,Clonidine-induced hypothermia: Possible involvement of cholinergic and serotonergic mechanisms,Lin,2004,1
10.1007/bf00499835,"Effects of intracerebroventricular injection of clonidine on metabolic, respiratory, vasomotor and temperature responses in the rabbit",Lin,2004,1
10.1139/y79-002,Effects of brain monoamine depletion on chlorpromazine-induced hypothermia in rabbits,Lin,2011,1
10.1113/jphysiol.1978.sp012532,Effects of specific inhibitors of 5-hydroxytryptamine uptake on thermoregulation in rats.,Lin,2014,1
10.1016/j.socscimed.2005.11.042,“I thought it was only ordinary fever!” cultural knowledge and the micropolitics of therapy seeking for childhood febrile illness in Tanzania,Kamat,2006,1
10.1080/13648470.1998.9964548,Fake malaria and hidden parasites—the ambiguity of malaria,Muela,2010,1
10.1016/0001-706x(94)90020-5,"Recognition, treatment seeking behaviour and perception of cause of malaria among rural women in Uganda",Kengeya-Kayondo,2002,1
10.1016/0277-9536(92)90160-r,Malaria: Ethnomedical perceptions and practice in an Adangbe farming community and implications for control,Agyepong,2002,1
10.2190/q50p-rc1t-bh9e-350n,Issues in Collaborative Research between Health Educators and Medical Scientists: A Case Study,Brieger,2005,1
10.1016/j.ijantimicag.2009.10.008,First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis,Roberts,2009,2
10.1038/nrmicro862,Antimicrobial pharmacodynamics: critical interactions of 'bug and drug',Drusano,2004,3
10.1128/aac.46.6.1665-1670.2002,Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models,Andes,2002,1
10.1093/infdis/159.2.281,Comparative Antibiotic Dose-Effect Relations at Several Dosing Intervals in Murine Pneumonitis and Thigh-Infection Models,Leggett,2011,1
10.1097/00000542-197403000-00002,Inappropriate Response to Increased Plasma ADH during Mechanical Ventilation in Acute Respiratory Failure,Kumar,2006,1
10.1212/wnl.54.11.2153,Status epilepticus associated with cefepime,Dixit,2012,1
10.1086/598640,"Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997",Pfaller,2009,1
10.1097/qco.0b013e328353105c,Antibiotic dosing in children in Europe,Barker,2012,1
10.1093/jac/dkf130,Pharmacodynamics of cefepime in patients with Gram-negative infections,Tam,2002,2
10.1016/j.mce.2004.12.005,"Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues",Miki,2005,1
10.1210/jc.2002-020670,Systemic Distribution of Steroid Sulfatase and Estrogen Sulfotransferase in Human Adult and Fetal Tissues,Miki,2002,1
10.1016/0960-0760(95)00015-r,Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase,Falany,2002,1
10.1210/me.6.4.589,Estrogen sulfotransferase of the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA,Demyan,2004,1
10.1517/17425255.2011.570331,The effects of obesity on drug pharmacokinetics in humans,Morrish,2011,1
10.2146/ajhp080200,Estimation of creatinine clearance in morbidly obese patients,Demirovic,2009,1
10.1007/s11892-007-0076-5,"Obesity, diabetes, and chronic kidney disease",Eknoyan,2008,1
10.1111/j.1467-789x.2007.00311.x,Health risks associated with overweight and obesity,Kopelman,2007,1
10.1038/35007508,Obesity as a medical problem,Kopelman,2017,1
10.1001/jama.1991.03470020057032,The Impact of Obesity on Left Ventricular Mass and Geometry,Lauer,2011,1
10.1542/peds.2009-2810,Day-by-Day Postnatal Survival in Very Low Birth Weight Infants,Mohamed,2010,1
10.1016/s0378-3782(98)00052-8,Outcomes of children of extremely low birthweight and gestational age in the 1990's,Hack,2002,1
10.1016/s1084-2756(96)80047-9,School-age outcomes of children of extremely low birthweight and gestational age,Hack,2006,1
10.1136/bmj.306.6894.1715,Functional abilities at age 4 years of children born before 29 weeks of gestation.,Johnson,2009,1
10.1016/s0140-6736(88)92300-8,SURVIVAL OF THE SMALLEST Time Trends and Determinants of Mortality in a Very Preterm Population During the 1980s,HEINONEN,2003,1
10.1007/s40262-012-0018-5,The Clinical Relevance of Plasma Protein Binding Changes,Roberts,2012,2
10.1093/jac/dkaa170,Population pharmacokinetics of ceftazidime in critically ill children: impact of cystic fibrosis,Bui,2020,3
10.1146/annurev.pharmtox.48.113006.094708,Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics,Anderson,2007,2
10.1186/1742-4682-1-13,,Agutter,2004,1
10.1093/cid/ciz1155,Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase–4 and New Delhi Metallo-β-Lactamase–1,Yasmin,2019,5
10.1128/aac.45.4.1151-1161.2001,"Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of
            <i>Klebsiella pneumoniae</i>",Yigit,2002,1
10.1086/520193,Surveillance of Antimicrobial Use and Antimicrobial Resistance in United States Hospitals: Project ICARE Phase 2,Fridkin,2007,1
10.1086/422655,Vaccination: A Novel Approach to Reduce Antibiotic Resistance,Klugman,2004,1
10.1038/nm839,Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States,McCormick,2003,1
10.1093/aje/154.1.85,Interpreting Results from Trials of Pneumococcal Conjugate Vaccines: A Statistical Test for Detecting Vaccine-induced Increases in Carriage of Nonvaccine Serotypes,Lipsitch,2002,1
10.1214/aoms/1177729756,Transformations Related to the Angular and the Square Root,Freeman,2007,1
10.1001/jama.2016.0287,The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3),Singer,2016,3
10.1038/clpt.1990.149,Pharmacokinetics of cefepime in subjects with renal insufficiency,Barbhaiya,2009,1
10.1001/archsurg.1992.01420010097015,Guidelines for Clinical Care: Anti-infective Agents for Intra-abdominal Infection,Bohnen,2011,1
10.1139/y79-182,The role of the cholinergic systems in the central control of thermoregulation in rats,Lin,2011,1
10.1097/ftd.0000000000000937,Barriers and Facilitators in the Clinical Implementation of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: A Critical Review,Abdulla,2021,2
10.1186/s13054-020-03272-z,Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT),Abdulla,2020,1
10.1128/aac.29.2.188,Imipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections,MacGregor,2012,1
10.1159/000170321,Quantification of Hemodialysis: Analysis of Methods and the Relevance to Patient Outcome,Clark,2008,1
10.1203/00006450-199704001-01062,Shortterm outcome of infants born at the limit of viability in two Swedish tertiary care centers. † 1043,Serenius,2007,1
10.1097/pcc.0000000000000225,Pediatric Severe Sepsis in U.S. Children’s Hospitals*,Balamuth,2014,3
10.1542/peds.2010-3513,An Emergency Department Septic Shock Protocol and Care Guideline for Children Initiated at Triage,Larsen,2011,1
10.1007/s00134-004-2210-z,Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock,Dellinger,2004,1
10.1093/clinids/5.1.35,The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations,Weinstein,2011,1
10.1046/j.1365-3156.2003.01058.x,Recognizing childhood illnesses and their traditional explanations: exploring options for care-seeking interventions in the context of the IMCI strategy in rural Ghana,Hill,2004,1
10.1590/s0036-36341998000400003,La mortalidad por enfermedad diarreica en México: ¿problema de acceso o de calidad de atención?,Reyes,2007,1
10.1007/s00134-017-4878-x,"Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach",Bassetti,2017,1
10.3324/haematol.2015.125484,Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement,Girmenia,2015,1
10.1046/j.1523-1755.2001.0600031154.x,A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure,Mehta,2002,1
10.1016/s1073-4449(97)70018-9,Transport Characteristics of the Slow Therapies: Implications for Achieving Adequacy of Dialysis in Acute Renal Failure,Sigler,2017,1
10.1016/s0272-6386(12)70162-2,Factors Affecting Delivery of High-Efficiency Dialysis Using Temporary Vascular Access,Kelber,2014,1
10.1016/s0272-6386(12)81124-3,Rate-Related Recirculation: The Effect of Altering Blood Flow on Dialyzer Recirculation,Sherman,2014,1
10.1038/ki.1990.52,Assessing the adequacy of dialysis,Hakim,2007,1
10.1177/089686088800800110,Beta-2 Microglobulin in Peritoneal Dialysis Patients: Serum Levels and Peritoneal Clearances,DiRaimondo,2020,1
10.1038/ki.1987.59,Maximum ultrafiltration rates during peritoneal dialysis in rats,Levin,2007,1
10.1016/s0006-3495(74)85924-2,Concentration Polarization in an Ultrafiltering Capillary,Deen,2009,1
10.1056/nejm200105033441801,Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance,Tuomilehto,2002,1
10.1007/bf00276995,"Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed Type 2 (non-insulin-dependent) diabetic subjects",Uusitupa,2004,1
10.1016/s1473-3099(01)00093-7,Immunotherapy of sepsis,van der Poll,2002,1
10.1038/330662a0,Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia,Tracey,2003,1
10.1097/pcc.0000000000001497,Ceftaroline for Suspected or Confirmed Invasive Methicillin-Resistant Staphylococcus aureus,Cies,2018,4
10.1093/jac/dku322,Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia,Barber,2014,1
10.1097/ccm.0000000000002817,β-lactam Therapeutic Drug Management in the PICU*,Cies,2017,3
10.2146/ajhp080434,"Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists",Rybak,2008,1
10.1128/aac.21.4.575,Vancomycin pharmacokinetics in normal and morbidly obese subjects,Blouin,2012,1
10.1056/nejm200005183422002,Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical Ventilation,Kress,2002,1
10.1097/00003246-199502000-00014,Comparison of propofol and midazolam for sedation in intensive care unit patients,Ronan,2003,1
10.1016/s0749-0704(18)30380-4,The Role of Sedation in the ICU Patient with Pain and Agitation,Crippen,2018,1
10.7326/0003-4819-94-3-293,Prognosis in Nontraumatic Coma,LEVY,2013,1
10.1212/wnl.0000000000002455,Antibiotic-associated encephalopathy,Bhattacharyya,2016,2
10.1016/j.coph.2015.06.002,"Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization",Sime,2015,1
10.1186/1471-2369-14-250,A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations,Udy,2013,2
10.1007/s00134-013-2909-9,Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis,Shimamoto,2013,1
10.1128/aac.25.4.433,Pharmacokinetics of vancomycin in patients with various degrees of renal function,Matzke,2012,1
10.1023/a:1016215116835,,Ette,2002,1
10.7326/0003-4819-119-4-199308150-00003,Detection of Bacteremia in Adults: Consequences of Culturing an Inadequate Volume of Blood,Mermel,2013,1
10.1097/pcc.0000000000002198,Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children,Weiss,2020,4
10.1097/pcc.0000000000000858,Protocolized Treatment Is Associated With Decreased Organ Dysfunction in Pediatric Severe Sepsis*,Balamuth,2016,1
10.1097/ccm.0b013e3181cc4824,Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department*,Gaieski,2010,1
10.1097/01.ccm.0000298158.12101.41,Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008,Dellinger,2009,1
10.1097/01.ccm.0000262946.68003.21,Is severe sepsis increasing in incidence AND severity?*,Esper,2007,1
10.1097/01.ccm.0000045026.81584.6f,"Bacteremic sepsis in intensive care: Temporal trends in incidence, organ dysfunction, and prognosis",Hugonnet,2003,1
10.1007/s001340100955,"Acute respiratory distress syndrome among trauma patients: trends in ICU mortality, risk factors, complications and resource utilization",Navarrete-Navarro,2003,1
10.1038/sj.bjp.0704496,"The <i>β</i>
-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA<sub>A</sub>
 receptors",Sugimoto,2005,1
10.1038/367607a0,Molecular and cellular mechanisms of general anaesthesia,Franks,2003,1
10.1111/j.1476-5381.1990.tb14145.x,Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor,Dodson,2012,1
10.1113/jphysiol.1976.sp011530,Drug blockade of open end-plate channels.,Adams,2014,1
10.1097/01.ccm.0000254067.14607.eb,Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Critical Care Medicine Task Force 2004–2005,Davidson,2007,1
10.1097/00002800-200201000-00017,Why Do Nurses See Families as “Trouble?”,CLARK,2003,1
10.2307/3521954,CE Credit: Original Research: Family Presence during Invasive Procedures and Resuscitation,Meyers,2008,1
10.1016/s0002-9378(94)70297-7,A longitudinal study of cardiac output in normal human pregnancy,Mabie,2013,1
10.1016/0002-9378(87)90146-3,Serial noninvasive evaluation of cardiovascular hemodynamics during pregnancy,Mashini,2013,1
10.1161/01.cir.58.6.1072,Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.,Sahn,2012,1
10.1128/aac.45.12.3548-3554.2001,"Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum β-Lactamase-Producing
            <i>Enterobacteriaceae</i>",Thomson,2002,2
10.1093/clinids/23.1.118,Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center,Rice,2011,1
10.1093/cid/cis916,Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters,Lee,2012,1
10.1128/aac.01509-06,"Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing
            <i>Enterobacteriaceae</i>
            : Importance of Inadequate Initial Antimicrobial Treatment",Tumbarello,2007,1
10.1128/aac.50.4.1257-1262.2006,"Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing
            <i>Enterobacteriaceae</i>",Schwaber,2006,1
10.1016/j.ijantimicag.2012.06.022,Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method,Carlier,2012,2
10.1002/jssc.200600081,Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids,Samanidou,2006,1
10.1016/s0378-4347(99)00241-8,Simultaneous quantification of amoxycillin and metronidazole in plasma using high-performance liquid chromatography with photodiode array detection,Menelaou,2002,1
10.1016/s0378-4347(00)84862-8,Sensitive high-performance liquid chromatographic method for the determination of metronidazole and metabolites,Jensen,2002,1
10.1128/aac.13.2.205,Use of High-Pressure Liquid Chromatography to Determine Plasma Levels of Metronidazole and Metabolites After Intravenous Administration,Wheeler,2012,1
10.1214/aos/1176346060,On the Convergence Properties of the EM Algorithm,Wu,2007,2
10.1086/591453,Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points,Thom,2008,1
10.1016/s0195-6701(98)90065-2,Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control,Hansen,2004,1
10.1016/0195-6701(94)90117-1,"Klebsiella bacteraemia: a report of 101 cases from National University Hospital, Singapore",Lee,2004,1
10.1002/1097-0142(19891201)64:11<2368::aid-cncr2820641129>3.0.co;2-h,Klebsiella bacteremia. A 10-year review in a cancer institution,Bodey,2006,1
10.1093/clinids/1.5.736,Epidemiology of Klebsiella and Hospital-Associated Infections,Montgomerie,2011,1
10.1159/000346629,Impact of Severe Sepsis on Serum and Urinary Biomarkers of Acute Kidney Injury in Critically Ill Children: An Observational Study,Di Nardo,2013,2
10.1007/s00134-010-1887-4,Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury,Mårtensson,2010,1
10.1159/000109102,Could Neutrophil-Gelatinase-Associated Lipocalin and Cystatin C Predict the Development of Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Patients with Stable Angina and Normal Serum Creatinine Values?,Bachorzewska-Gajewska,2007,1
10.1159/000093961,Neutrophil-Gelatinase-Associated Lipocalin and Renal Function after Percutaneous Coronary Interventions,Bachorzewska-Gajewska,2006,1
10.4065/79.2.211,Contrast Nephropathy After Coronary Angiography,Gami,2009,1
10.1259/bjr.72.859.10624328,Comparison of iodixanol and iohexol in renal impairment.,Chalmers,2014,1
10.1542/peds.2010-2895,Implementation of Goal-Directed Therapy for Children With Suspected Sepsis in the Emergency Department,Cruz,2011,1
10.1186/cc8138,One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study,Puskarich,2009,1
10.1016/j.mayocp.2011.12.011,Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design,Vardakas,2012,1
10.1128/aac.35.11.2246,Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity,Kureishi,2012,1
10.1016/j.ijid.2021.05.044,Comparison of piperacillin plasma concentrations in a prospective randomised trial of extended infusion versus intermittent bolus of piperacillin/tazobactam in paediatric patients,Chongcharoenyanon,2021,1
10.1016/s0924-8579(02)00031-6,Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs,Mouton,2002,1
10.1128/aac.35.9.1834,Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro,Odenholt-Tornqvist,2012,1
10.1097/pcc.0b013e3182917fad,Trends in the Epidemiology of Pediatric Severe Sepsis*,Hartman,2013,1
10.1001/jama.2012.384,"Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009",Lindenauer,2012,1
10.1128/aac.32.6.848,Vancomycin pharmacokinetics in patients with various degrees of renal function,Rodvold,2012,1
10.1097/00003246-198907000-00006,Prognostic significance of early clinical manifestations in postanoxic coma,BERTINI,2006,1
10.2165/00003495-199549040-00008,Ceftazidime,Rains,2009,1
10.1007/s10928-013-9302-8,Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian,Tatarinova,2013,1
10.2165/00003088-199835040-00004,Drug Disposition in Cystic Fibrosis,Rey,2006,1
10.1097/00003246-198501000-00009,Mean airway pressure vs. positive end-expiratory pressure during mechanical ventilation,PESENTI,2006,1
10.1001/jama.1997.03540370048035,Magnitude and Duration of the Effect of Sepsis on Survival,Quartin,2011,1
10.1097/00005072-195207000-00010,Fatality Following the Use of Intrathecal Penicillin,Cohen,2008,1
10.1128/aac.06365-11,Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification,Esterly,2012,1
10.1097/00003246-200102000-00030,Impaired target site penetration of β -lactams may account for therapeutic failure in patients with septic shock,Joukhadar,2003,1
10.1016/s0025-7125(16)31440-7,Principles of Antibiotic Tissue Penetration and Guidelines for Pharmacokinetic Analysis,Schentag,2016,1
10.1093/jac/4.suppl_a.13,Comparison of the intrarenal disposition of tobramycin and gentamicin: therapeutic and toxicologic answers,Whelton,2012,1
10.1113/jphysiol.1971.sp009330,"Influence of ambient temperature on the thermoregulatory responses to 5-hydroxytryptamine, noradrenaline and acetylcholine injected into the lateral cerebral ventricles of sheep, goats and rabbits",Bligh,2014,1
10.1517/17425255.2011.574127,The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function,Zhou,2011,1
10.1016/j.cryobiol.2008.09.006,Changes in cardiovascular β-adrenoceptor responses during hypothermia,Han,2008,1
10.1016/s0300-9572(01)00357-4,Effects of epinephrine on the myocardial performance and haemodynamics of the isolated rat heart during moderate hypothermia — importance of calcium homeostasis,Schiffmann,2002,1
10.1161/01.res.61.6.761,Inotropic response to hypothermia and the temperature-dependence of ryanodine action in isolated rabbit and rat ventricular muscle: implications for excitation-contraction coupling.,Shattock,2012,1
10.1128/aac.01696-09,Pharmacokinetics of Cefotaxime and Desacetylcefotaxime in Infants during Extracorporeal Membrane Oxygenation,Ahsman,2010,1
10.1093/nar/gkm958,"DrugBank: a knowledgebase for drugs, drug actions and drug targets",Wishart,2007,1
10.1007/bf02491068,Determination of eight penicillins in serum from cattle and pigs by generic HPLC method,Sørensen,2006,1
10.1080/10826079808001260,Determination of Benzylpenicillin and Other Beta-Lactam Antibiotics in Plasma and Tissues Using Liquid Chromatography-Mass Spectrometry for Residual and Pharmacokinetic Studies,Hormazábal,2007,1
10.1021/jf00069a018,Depletion of intramuscularly injected procaine penicillin G from tissues of swine. A comparison of HPLC and bioassay procedures,Moats,2005,1
10.1124/mol.59.2.386,"cDNA Cloning and Initial Characterization of CYP3A43, a Novel Human Cytochrome P450",Domanski,2018,1
10.1093/emboj/19.17.4688,Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1,Flouriot,2002,1
10.1016/s1521-6918(03)00028-3,Stress-related mucosal disease in critically ill patients,Duerksen,2003,1
10.1016/0014-2999(91)90077-4,Nifedipine versus cimetidine in prevention of stress-induced gastric ulcers in rats,Al-Mashhadani,2002,1
10.1086/514621,Pharmacodynamic Interactions of Antibiotics Alone and in Combination,Schentag,2007,1
10.1093/oxfordjournals.aje.a112959,ROLE OF RISK FACTORS IN COMPLICATIONS OF DIABETES MELLITUS1,DUPREE,2017,1
10.1016/s0002-9343(84)80074-1,Role for Dual Individualization with Cefmenoxime,Schentag,2014,1
10.1097/01.ccm.0000050454.01978.3b,2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference,Levy,2003,1
10.1001/jama.286.14.1754,Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients,Ferreira,2003,1
10.1016/j.clinthera.2005.06.013,"A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit",Mouton,2005,1
10.1038/clpt.1984.187,Ceftazidime disposition in acute and stable cystic fibrosis,Leeder,2010,1
10.1016/j.cmi.2020.04.022,Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus,Salvador,2020,1
10.3791/58148,Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses,Schuster,2018,1
10.2147/clep.s72282,Sepsis in Canadian children: a national analysis using administrative data,Thompson,2014,1
10.1093/ndt/gfm713,The neurotoxicity and safety of treatment with cefepime in patients with renal failure,Sonck,2008,1
10.1086/516284,State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men,Craig,2007,3
10.1097/00003246-199606000-00010,Comparative study of propofol versus midazolam in the sedation of critically ill patients,Chamorro,2003,1
10.1097/00003246-199209000-00024,A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants,KLESSIG,2006,1
10.1681/asn.v85804,Extracorporeal therapy requirements for patients with acute renal failure.,Clark,2021,1
10.1128/aac.48.12.4718-4724.2004,Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation,Lodise,2004,1
10.1128/aac.42.5.1098,Levofloxacin Population Pharmacokinetics and Creation of a Demographic Model for Prediction of Individual Drug Clearance in Patients with Serious Community-Acquired Infection,Preston,2018,1
10.1093/biomet/73.3.645,A maximum likelihood estimation method for random coefficient regression models,MALLET,2007,1
10.2307/2111343,Scobit: An Alternative Estimator to Logit and Probit,Nagler,2007,2
10.1016/s0140-6736(05)71048-5,4 million neonatal deaths: When? Where? Why?,Lawn,2005,1
10.1016/s0140-6736(04)16511-2,Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic?,Walker,2004,1
10.1111/j.1728-4457.2001.00771.x,The Impact of HIV/AIDS on Adult Mortality in Zimbabwe,Feeney,2004,1
10.1002/ppul.1950040403,Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis,McCarty,2007,1
10.1016/s0140-6736(84)91473-9,ADVERSE REACTIONS TO PIPERACILLIN IN CYSTIC FIBROSIS,Brock,2003,1
10.1002/jcph.566,Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic‐derived dose justification for phase 3 studies in patients with nosocomial pneumonia,Xiao,2015,3
10.1086/653057,Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!,Ambrose,2010,1
10.2146/ajhp060239,Estimating glomerular filtration rate with a modification of diet in renal disease equation: Implications for pharmacy,Spruill,2007,1
10.1086/498909,The Duration of Hypotension before the Initiation of Antibiotic Treatment Is a Critical Determinant of Survival in a Murine Model of<i>Escherichia coli</i>Septic Shock: Association with Serum Lactate and Inflammatory Cytokine Levels,Kumar,2005,1
10.1007/s40262-018-0682-1,Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance,Béranger,2018,3
10.1186/s12882-017-0539-0,Accuracy of cystatin C in prediction of acute kidney injury in children; serum or urine levels: which one works better? A systematic review and meta-analysis,Nakhjavan-Shahraki,2017,1
10.1053/j.ajkd.2004.09.028,Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001,Hui-Stickle,2005,1
10.1007/s002460010238,Acute Renal Insufficiency and Renal Replacement Therapy After Pediatric Cardiopulmonary Bypass Surgery,Kist-van Holthe tot Echten,2014,1
10.1128/aac.38.4.761,Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate,Bradford,2012,1
10.1007/s001340050805,"Sedation, where are we now?",Shelly,2002,1
10.1093/clinids/24.supplement_1.s169,Reports on Surveillance of Antimicrobial Resistance in Individual Countries,Rahal,2011,1
10.1007/s00467-006-0244-x,Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease,Mitsnefes,2006,1
10.1681/asn.2005090934,Towards a Definition and Classification of Acute Kidney Injury,Warnock,2005,1
10.3389/fendo.2018.00550,Vitamin D Toxicity–A Clinical Perspective,Marcinowska-Suchowierska,2018,1
10.1016/j.abb.2010.10.012,"1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D",DeLuca,2010,1
10.1073/pnas.89.17.8097,"Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.",Demay,2006,1
10.1084/jem.79.2.137,STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES,Avery,2004,1
10.1080/21505594.2016.1222343,The global epidemiology of carbapenemase-producing Enterobacteriaceae,van Duin,2016,1
10.1007/s10096-015-2550-3,Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong,Ho,2016,1
10.1007/s00228-012-1413-4,Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants,Li,2013,1
10.1177/0091270005283283,Population Pharmacokinetics and Pharmacodynamics of Meropenem in Pediatric Patients,Du,2006,1
10.1016/0732-8893(95)00052-c,Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young,Kearns,2002,1
10.1128/aac.20.4.487,Clinical Pharmacology of Cefotaxime in Pediatric Patients,Kafetzis,2012,1
10.1097/inf.0b013e3182a743c7,Population Pharmacokinetics of Piperacillin/Tazobactam in Critically Ill Young Children,Cies,2013,3
10.1111/j.1532-5415.1985.tb07117.x,Longitudinal Studies on the Rate of Decline in Renal Function with Age,Lindeman,2015,1
10.1159/000179347,Structure of the Arteriole-Glomerular Units in Different Zones of the Kidney,Ljungqvist,2008,1
10.1128/aac.18.1.148,Penicillin-binding proteins in bacteria,Georgopapadakou,2012,1
10.1038/ki.1983.101,Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury,Verger,2007,1
10.1038/ki.1978.17,Determinants of low clearances of small solutes during peritoneal dialysis,Nolph,2007,1
10.1128/aac.02139-13,Developmental Pharmacokinetics of Piperacillin and Tazobactam Using Plasma and Dried Blood Spots from Infants,Cohen-Wolkowiez,2014,2
10.1186/1471-2334-10-72,"Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study",Joly-Guillou,2010,1
10.1016/j.diagmicrobio.2008.04.012,"Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006",Zhanel,2008,1
10.1016/j.ajic.2003.09.002,"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003",A report from the NNIS System,2003,1
10.1053/j.ajkd.2010.03.026,Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2,Stevens,2010,1
10.1056/nejm199611283352203,Development and Progression of Renal Disease in Pima Indians with Non-Insulin-Dependent Diabetes Mellitus,Nelson,2002,1
10.1056/nejm199311113292004,The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy,Lewis,2002,1
10.1002/phar.1567,"Pharmacokinetics of Continuous-Infusion Meropenem for the Treatment of <i>Serratia marcescens</i>
 Ventriculitis in a Pediatric Patient",Cies,2015,4
10.2165/11536640-000000000-00000,The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune Disease,Sherwin,2010,1
10.2133/dmpk.24.53,"A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates",Jamei,2009,1
10.1080/00498250310001646353,Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors,Proctor,2004,1
10.1007/s002280050706,"Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions",Katoh,2002,1
10.1345/aph.1e271,Pharmacokinetics and Pharmacodynamics of Meropenem in Febrile Neutropenic Patients with Bacteremia,Ariano,2004,1
10.1093/ajhp/61.12.1264,Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts,Kotapati,2019,1
10.1038/ki.1990.206,Optimization of high-efficiency hemodialysis by detection and correction of fistula dysfunction,Windus,2007,1
10.1097/pcc.0b013e3181e28894,"Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults*",Bizzarro,2010,1
10.1016/0732-8893(95)00053-d,Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins,Craig,2002,1
10.1128/aac.26.5.678,Postantibiotic effect of imipenem on Pseudomonas aeruginosa,Bustamante,2012,1
10.1128/aac.39.8.1683,"Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program",Drusano,2012,1
10.1023/a:1012299115260,,Beal,2002,1
10.1128/aac.43.3.623,Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria,Kashuba,2018,2
10.5694/j.1326-5377.1977.tb113913.x,EVALUATION OF NEPHROTOXIC AND OTOTOXIC EFFECTS OF TOBRAMYCIN IN WORLDWIDE STUDY,Bendush,2019,1
10.1093/infdis/130.6.656,Renal Parenchymal Accumulation of Aminoglycoside Antibiotics in Rats,Luft,2011,1
10.1093/cid/cis545,Does the Piperacillin Minimum Inhibitory Concentration for Pseudomonas aeruginosa Influence Clinical Outcomes of Children With Pseudomonal Bacteremia?,Tamma,2012,1
10.1128/aac.41.4.721,Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam,Lister,2018,1
10.3201/eid0702.010238,Controversies about Extended-Spectrum and AmpC Beta-Lactamases,Thomson,2009,1
10.5863/1551-6776-22.6.467,Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report,Cies,2017,2
10.2165/00003088-200645110-00003,Guidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic Considerations,Bartelink,2006,1
10.2165/00003088-200645010-00001,"Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children",Bj??rkman,2006,1
10.1016/0006-2952(94)90520-7,Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance,Brian Houston,2002,1
10.1016/0006-2952(92)90332-d,Induction of propranolol metabolism by the azo dye sudan III in rats,Ishida,2002,1
10.1016/0009-2797(84)90080-2,Induction of hepatic microsomal drug metabolism by azo compounds: A structure-activity relationship,Fujita,2002,1
10.1016/s0021-9258(19)52451-6,PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT,Lowry,2021,1
10.1085/jgp.19.2.283,ACETYLATION OF TYROSINE IN PEPSIN,Herriott,2004,1
10.1128/aac.33.12.2083,Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1,Koshida,2012,1
10.1016/s0140-6736(89)91308-1,ASSESSMENT OF CLINICAL CRITERIA FOR IDENTIFICATION OF SEVERE ACUTE LOWER RESPIRATORY TRACT INFECTIONS IN CHILDREN,Campbell,2003,1
10.1016/s0140-6736(88)90213-9,SIMPLE CLINICAL SIGNS FOR DIAGNOSIS OF ACUTE LOWER RESPIRATORY INFECTIONS,Campbell,2003,1
10.1016/0035-9203(86)90241-5,"Acute respiratory infections in children under five years. Control project in Bagamoyo District, Tanzania",Mtango,2004,1
10.2105/ajph.70.12.1286,How many die? A set of demographic estimates of the annual number of infant and child deaths in the world.,Gwatkin,2008,1
10.1002/phar.1476,Pharmacokinetics of Continuous-Infusion Meropenem in a Pediatric Patient Receiving Extracorporeal Life Support,Cies,2014,1
10.1128/aac.00656-13,Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane,VanScoy,2013,1
10.1093/biomet/66.2.237,A Bayesian extension of the minimum AIC procedure of autoregressive model fitting,AKAIKE,2007,1
10.1046/j.1523-1755.2003.00928.x,Differential gene expression following early renal ischemia/reperfusion,Supavekin,2004,1
10.1126/science.286.5439.531,Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,Golub,2002,1
10.1093/jac/dkx209,Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships,Imani,2017,4
10.1517/14740338.2012.643866,Adverse reactions to β-lactam antimicrobials,Lagacé-Wiens,2012,1
10.1016/j.ajem.2013.09.017,Computerized provider order entry improves compliance of vancomycin dosing guidelines in the emergency department,Frankel,2013,1
10.1001/jama.1997.03540280050033,Factors Related to Errors in Medication Prescribing,Lesar,2011,1
10.1016/s0378-4347(00)82563-3,"Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography",Ocampo,2002,1
10.1016/s0378-4347(00)81779-x,Analysis of piperacillin using high-performance liquid chromatography,Aravind,2002,1
10.1002/cpt197926141,Piperacillin kinetics,Batra,2016,1
10.1212/01.wnl.0000187079.12413.6a,Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function,Capparelli,2006,1
10.1177/0091270006286433,Population Pharmacokinetics of Oxycodone in Children 6 Months to 7 Years Old,El-Tahtawy,2006,1
10.1016/0304-3959(96)03149-1,Mothers' attitudes and behavior toward medicating children's pain,Forward,2002,1
10.1016/0304-3959(93)90165-l,Patient-related barriers to management of cancer pain,Ward,2003,1
10.1016/0885-3924(91)90518-9,Correlation of patient and caregiver ratings of cancer pain,Grossman,2004,1
10.7326/0003-4819-78-2-173,Undertreatment of Medical Inpatients with Narcotic Analgesics,MARKS,2013,1
10.1016/s1473-3099(14)70036-2,Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions,Roberts,2014,1
10.1093/jac/45.4.483,Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa,Smith,2002,1
10.1128/aac.31.10.1529,Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila,Havlichek,2012,1
10.1097/inf.0b013e31829ff7aa,"Simplified Antibiotic Regimens for the Management of Clinically Diagnosed Severe Infections in Newborns and Young Infants in First-level Facilities in Karachi, Pakistan",Zaidi,2013,1
10.1097/inf.0b013e318256f86c,Community-based Treatment of Serious Bacterial Infections in Newborns and Young Infants,Zaidi,2012,1
10.1124/jpet.300.2.361,The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms: Table 1,McCarver,2003,1
10.1007/bf00332483,Cytosolic epoxide hydrolase in humans: development and tissue distribution,Pacifici,2004,1
10.1159/000137807,Epoxide Hydrolase in Human Fetal Liver,Pacifici,2008,1
10.1093/jac/dkaa468,Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study,Wu,2020,1
10.1086/514622,The Pharmacodynamics of β‐Lactams,Turnidge,2007,1
10.1128/jb.58.4.475-490.1949,THE SLOW RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN,Eagle,2020,1
10.1001/jama.1995.03530200027032,A Controlled Trial to Improve Care for Seriously III Hospitalized Patients,Connors,2011,1
10.1016/s0022-5223(19)43068-7,Epileptogenic threshold of parenteral penicillin in dogs,Wyant,2019,1
10.1016/s0022-5223(19)43391-6,Penicillin epilepsy,Dobell,2019,1
10.1097/01.ccm.0000217961.75225.e9,Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*,Kumar,2006,1
10.1086/377200,<i>Pseudomonas aeruginosa</i>Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome,Kang,2003,1
10.1111/j.1365-2796.1992.tb00946.x,Patients at risk for inappropriate antibiotic treatment of bacteraemia,LEIBOVICI,2009,1
10.1001/archinte.1985.00360100064009,Antibiotic-Resistant Flora in Nursing Home Patients Admitted to the Hospital,Gaynes,2011,1
10.1053/j.ackd.2005.07.013,Epidemiology of Pediatric Chronic Kidney Disease,Chadha,2005,1
10.1097/00003246-200010000-00006,Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration,Ververs,2003,1
10.2165/00003088-199324050-00002,Drug Dosage in Patients during Continuous Renal Replacement Therapy,Reetze-Bonorden,2009,1
10.5144/0256-4947.2015.423,"Maternal colonization of group B streptococcus: prevalence, associated factors and antimicrobial resistance",Khan,2017,1
10.3923/jms.2008.574.578,"Vaginal Colonization of Group B Streptococci During Late Pregnancy in Southeast of Iran: Incidence, Serotype Distribution and Susceptibility to Antibiotics",Mansouri,2009,1
10.1007/s100960100505,Serotyping and Antimicrobial Susceptibility of Group B Streptococcus Over an Eight-Year Period in Southern Taiwan,Ko,2003,1
10.1111/j.1365-2125.1994.tb04260.x,The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.,Verhagen,2012,1
10.2165/00003088-198106020-00004,Clinical Pharmacokinetics of Probenecid,Cunningham,2007,1
10.1128/aac.01183-09,"Clinical Pharmacodynamics of Cefepime in Patients Infected with
            <i>Pseudomonas aeruginosa</i>",Crandon,2009,1
10.1128/aac.47.11.3442-3447.2003,"Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study",Zanetti,2003,1
10.1093/jac/32.suppl_b.165,A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections,Leophonte,2012,1
10.1016/s0021-9258(18)84277-6,ON TYROSINE AND TRYPTOPHANE DETERMINATIONS IN PROTEINS,Folin,2021,1
10.1016/s0021-9258(18)85884-7,"COLORIMETRIC METHODS FOR THE SEPARATE DETERMINATION OF TYROSINE, TRYPTOPHANE, AND CYSTINE IN PROTEINS",Folin,2021,1
10.1128/aac.25.5.633,"Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid",Barry,2012,1
10.1186/s13054-019-2378-9,Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR),Guilhaumou,2019,1
10.1093/jac/dkn522,Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis,Seguin,2009,1
10.1093/jac/dkh268,Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients,Buijk,2004,1
10.1093/jac/36.suppl_a.191,Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery,Geroulanos,2012,1
10.1016/j.jchromb.2008.01.037,"Simultaneous determination of five β-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection",Denooz,2008,1
10.1136/archdischild-2015-308255,Variation in paediatric hospital antibiotic guidelines in Europe,Spyridis,2015,1
10.1542/peds.2011-1330,Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2 to 24 Months,Roberts,2011,1
10.1097/01.pec.0000081238.98249.40,Validation of a decision rule identifying febrile young girls at high risk for urinary tract infection,GORELICK,2004,1
10.1001/jama.277.6.488,Clinical prediction rules. A review and suggested modifications of methodological standards,Laupacis,2003,1
10.1016/s0002-9343(96)00110-6,Safety of cefepime: A new extended-spectrum parenteral cephalosporin,Neu,2002,1
10.1016/0002-9343(85)90271-2,Advances in cephalosporin therapy,Neu,2004,1
10.1016/0002-9343(85)90267-0,Ceftazidime in the treatment of nosocomial sepsis,Young,2004,1
10.1016/s0002-9343(84)80094-7,Multicenter Clinical Trial of Cefoperazone Sodium in the United States,Cohen,2014,1
10.1093/clinids/5.supplement_1.s145,Cefoperazone for the Treatment of Acute Urinary Tract Infection: Multicentered Comparative and Noncomparative Studies,File,2011,1
10.1136/ard.44.11.729,Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: a new complication.,Munoz-Gomez,2008,1
10.1111/j.0954-6820.1971.tb07458.x,DIAGNOSIS OF SECONDARY GENERALIZED AMYLOIDOSIS BY FINE NEEDLE BIOPSY OF THE SKIN,Westermark,2010,1
10.1093/jac/dkq184,Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics,Ulldemolins,2010,1
10.1007/bf01833876,"Dicloxacillin and flucloxacillin: Pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration",Røder,2005,1
10.3109/00365548609032348,Single-dose Pharmacokinetics of Dicloxacillin in Healthy Subjects of Young and Old Age,Löfgren,2007,1
10.1016/s0140-6736(71)91873-3,RAPID EVALUATION OF CREATININE CLEARANCE,Siersbæk-Nielsen,2003,1
10.1038/nrneurol.2012.183,Sepsis-associated encephalopathy,Gofton,2012,1
10.1016/s0378-4347(98)00407-1,Alternative method for determination of ceftazidime in plasma by high-performance liquid chromatography,Hanes,2002,1
10.1128/aac.42.7.1842,Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms,Kashuba,2018,1
10.1093/infdis/129.2.187,Antibacterial Activity in Serum and Urine as a Therapeutic Guide in Bacterial Infections,Klastersky,2011,1
10.1007/s40262-015-0291-1,Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design,Leroux,2015,1
10.1016/j.cmpb.2007.12.002,Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R,Comets,2008,1
10.2307/2532694,Adjusted P-Values for Simultaneous Inference,Wright,2006,1
10.1097/00000658-194512260-00021,PRINCIPLES AND PRACTICE OF PENICILLIN THERAPY IN DISEASES OF THE NERVOUS SYSTEM,Walker,2008,1
10.1038/jp.2008.167,Care-seeking practices in rural Rajasthan: barriers and facilitating factors,Mohan,2008,1
10.1016/s0140-6736(05)66836-5,"Local understandings of vulnerability and protection during the neonatal period in Sylhet district, Bangladesh: a qualitative study",Winch,2005,1
10.1016/0277-9536(87)90276-0,"Cultural dimensions of hot, cold and sema in Sinhalese health culture",Nichter,2002,1
10.1038/jp.2010.154,Effect of ampicillin on bleeding time in very low birth-weight neonates during the first week after birth,Sheffield,2011,1
10.1160/th09-11-0799,Platelet function testing and risk of bleeding complications,Ferreiro,2010,1
10.1007/bf00558225,Pharmacokinetics of midazolam in patients recovering from cardiac surgery,Maitre,2004,1
10.1002/j.1875-9114.1985.tb03411.x,"Midazolam: The First Water-soluble Benzodiazepine; Pharmacology, Pharmacokinetics and Efficacy in Insomnia and Anesthesia",Kanto,2015,1
10.1177/106002809402800910,Meropenem: A New Carbapenem Antimicrobial,Pryka,2017,1
10.1128/aac.33.8.1232,"Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent",Sentochnik,2012,1
10.1128/jcm.44.5.1659-1664.2006,Trends in Production of Extended-Spectrum β-Lactamases among Enterobacteria of Medical Interest: Report of the Second Italian Nationwide Survey,Luzzaro,2006,1
10.1056/nejmra041359,The New β-Lactamases,Jacoby,2005,1
10.1128/aac.42.1.53,"Epidemiology and Successful Control of a Large Outbreak Due to
            <i>Klebsiella pneumoniae</i>
            Producing ExtendedSpectrum β-Lactamases",Peña,2018,1
10.1093/infdis/124.supplement_1.s24,A Virulent Nosocomial Klebsiella with a Transferable R Factor for Gentamicin: Emergence and Suppression,Martin,2011,1
10.1128/aac.02446-17,Avibactam Pharmacokinetic/Pharmacodynamic Targets,Nichols,2018,1
10.1002/psp4.32,Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction,Sundqvist,2015,1
10.1016/j.ejps.2014.02.010,"In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects",Sjögren,2014,1
10.1007/s11095-012-0844-z,An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine,Psachoulias,2012,1
10.1007/s11095-006-9209-9,Estimation of Intragastric Solubility of Drugs: In What Medium?,Vertzoni,2007,1
10.1023/a:1023493821302,,Chen,2003,1
10.1128/aac.47.10.3170-3178.2003,Population Pharmacokinetics of Ciprofloxacin in Pediatric and Adolescent Patients with Acute Infections,Payen,2003,1
10.1007/s002280100306,Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in children,Patoux,2003,1
10.1128/aac.19.3.450,Piperacillin pharmacokinetics in subjects with chronic renal failure,Thompson,2012,1
10.1016/j.drup.2011.02.005,Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective,Mouton,2011,1
10.1128/aac.43.10.2473,Use of Pharmacodynamic Indices To Predict Efficacy of Combination Therapy In Vivo,Mouton,2018,1
10.1093/infdis/140.4.629,Comparison of Techniques for Measurement of in Vitro Antibiotic Synergism,Norden,2011,1
10.1097/01.tp.0000235533.29300.e7,Multidrug Resistance Protein 2 Genetic Polymorphisms Influence Mycophenolic Acid Exposure in Renal Allograft Recipients,Naesens,2006,1
10.1097/01.asn.0000094083.82845.fa,Impaired Renal Secretion of Substrates for the Multidrug Resistance Protein 2 in Mutant Transport–Deficient (TR−) Rats,Masereeuw,2004,1
10.1111/j.1399-3046.2011.01502.x,Cystatin C and neutrophil gelatinase-associated lipocalin as markers of renal function in pediatric heart transplant recipients,Abraham,2011,1
10.1002/lt.20881,Estimation of glomerular filtration rates after orthotopic liver transplantation: Evaluation of cystatin C–based equations,Gerhardt,2006,1
10.1016/j.ijantimicag.2017.02.020,Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational study,Aardema,2017,1
10.1016/j.ijantimicag.2015.02.014,Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration,Jamal,2015,1
10.1128/aac.39.2.431,Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks,Huisman-de Boer,2012,1
10.2165/00003088-200544050-00007,Pharmacokinetic Evaluation of Meropenem and Imipenem in Critically Ill Patients with Sepsis,Novelli,2006,1
10.1093/jac/43.4.523,Continuous infusion versus intermittent administration of meropenem in critically ill patients,Thalhammer,2002,1
10.1007/bf01690745,Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA,Craig,2005,1
10.1016/0002-9343(87)90688-7,Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis,Weinstein,2004,1
10.1016/s0022-3476(78)80455-7,Oral antibiotic therapy for skeletal infections of children,Tetzlaff,2006,1
10.1016/s0022-3476(78)80095-x,Antibiotic concentrations in pus and bone of children with osteomyelitis,Tetzlaff,2006,1
10.1093/infdis/124.6.565,Experimental Osteomyelitis. II. Therapeutic Trials and Measurement of Antibiotic Levels in Bone,Norden,2011,1
10.1111/bcp.12053,Duration of vancomycin treatment for coagulase-negative<i>Staphylococcus</i>sepsis in very low birth weight infants,Linder,2012,1
10.1542/peds.2005-0552,Seventy-Five Years of Neonatal Sepsis at Yale: 1928–2003,Bizzarro,2005,1
10.1001/jama.292.19.2357,Neurodevelopmental and Growth Impairment Among Extremely Low-Birth-Weight Infants With Neonatal Infection,Stoll,2004,1
10.1016/0006-2952(90)90314-b,Sex difference in antipyrine 3-hydroxylation,Buters,2002,1
10.1016/j.ijantimicag.2014.01.027,Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis,Teo,2014,1
10.5414/cpp43360,Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen,Georges,2011,1
10.1097/ftd.0b013e318067de5c,Amoxicillin Pharmacokinetics in (Preterm) Infants Aged 10 to 52 Days: Effect of Postnatal Age,Pullen,2007,1
10.1542/peds.103.4.e49,Why Do Newborn Infants Have a High Plasma Creatinine?,Guignard,2004,1
10.1113/expphysiol.1984.sp002861,PERINATAL DEVELOPMENT OF TUBULAR FUNCTION IN THE PIG,Alt,2014,1
10.1097/qco.0b013e32835d19e0,How should we dose antibiotics for pneumonia in the ICU?,Udy,2013,1
10.1345/aph.1q708,Augmented Renal Clearance in the Critically Ill: How to Assess Kidney Function,Grootaert,2012,1
10.1093/ndt/gfh707,Assessment of renal function in recently admitted critically ill patients with normal serum creatinine,Hoste,2005,1
10.1097/00000542-198712000-00031,Two-hour <i>Versus</i>  22-hour Creatinine Clearance in Critically III Patients,SLADEN,2006,1
10.1016/0163-4453(93)92815-e,"Septic shock in critically ill patients: Aetiology, management and outcome",Dahmash,2005,1
10.1097/00003246-198308000-00013,Naloxone in septic shock,GROEGER,2006,1
10.2215/cjn.10741011,Pharmacokinetics and Pharmacodynamics of Piperacillin-Tazobactam in 42 Patients Treated with Concomitant CRRT,Bauer,2012,1
10.1097/ftd.0b013e3181e60ca6,Prospective Determination of Serum Ceftazidime Concentrations in Intensive Care Units,Aubert,2010,1
10.1093/jac/33.3.563,Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to <i>Pseudomonas aeruginosa</i>,Fantin,2007,1
10.1016/s0277-9536(97)00195-0,Treatment-seeking behaviour for malaria: A typology based on endemicity and gender,Tanner,2003,1
10.1016/0277-9536(93)90249-4,Determining malaria effects in rural Colombia,Bonilla,2002,1
10.1016/0277-9536(93)90250-8,The impact of malaria on labour use and efficiency in the Sudan,Nur,2002,1
10.1016/0277-9536(93)90248-3,Economic and demographic research on malaria: A review of the evidence,Gomes,2002,1
10.2307/2172908,The Decline in Maternal and Infant Mortality and its relation to Malaria Eradication,Meegama,2006,1
10.1152/ajpendo.00381.2004,"Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins",Pietiläinen,2004,1
10.1126/science.284.5418.1318,Bacterial Biofilms: A Common Cause of Persistent Infections,Costerton,2002,1
10.1128/aem.60.12.4339-4344.1994,Direct measurement of chlorine penetration into biofilms during disinfection,De Beer,2020,1
10.1016/0149-7634(80)90002-0,Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants,Clark,2003,1
10.1159/000212186,Exaggerated Response to (+)Amphetamine in Geriatric Gerbils,Tannen,2009,1
10.1002/jcph.1128,Optimizing Antibiotic Drug Therapy in Pediatrics: Current State and Future Needs,Le,2018,1
10.1097/inf.0b013e318170f8d2,"Meropenem Pharmacokinetics, Pharmacodynamics, and Monte Carlo Simulation in the Neonate",Bradley,2008,1
10.1016/j.ajic.2004.08.002,Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics,CARMEN,2005,1
10.1097/00000542-198908000-00015,Propofol,Sebel,2006,1
10.1056/nejmra035092,"Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children",Kearns,2003,1
10.1136/gut.32.11.1321,Small intestinal length: a factor essential for gut adaptation.,Weaver,2007,1
10.1016/s0095-5108(18)30844-3,Short Bowel Syndrome in Infancy: Etiology and Management,Ziegler,2018,1
10.1016/s0022-3476(72)80459-1,Factors correlating with a successful outcome following extensive intestinal resection in newborn infants,Wilmore,2006,1
10.1001/archsurg.1969.01340170012003,Enhanced Intestinal Absorption After Small Bowel Resection in Man,Weinstein,2011,1
10.1152/ajprenal.2000.278.6.f925,Decreased abundance of major Na<sup>+</sup>transporters in kidneys of rats with ischemia-induced acute renal failure,Kwon,2017,1
10.1074/jbc.274.23.16569,"Cloning, Tissue Distribution, Genomic Organization, and Functional Characterization of NBC3, a New Member of the Sodium Bicarbonate Cotransporter Family",Pushkin,2002,1
10.1023/a:1006820509480,,Munch-Ellingsen,2002,1
10.1164/rccm.200207-682oc,The Epidemiology of Severe Sepsis in Children in the United States,Watson,2003,2
10.1097/00006454-199011000-00009,A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience,GLADSTONE,2006,1
10.1001/jama.1996.03540200031027,"Viability, Morbidity, and Resource Use Among Newborns of 501-to 800-g Birth Weight",Tyson,2011,1
10.1097/ccm.0b013e3181aab3d0,Principles of antibacterial dosing in continuous renal replacement therapy,Choi,2009,1
10.1093/cid/cix783,"Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to
          Carbapenem-Resistant Enterobacteriaceae",van Duin,2017,1
10.1093/jac/dkr240,Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009),Lascols,2011,1
10.1128/jcm.02458-09,"Evaluation of Updated Interpretative Criteria for Categorizing
            <i>Klebsiella pneumoniae</i>
            with Reduced Carbapenem Susceptibility",Endimiani,2010,1
10.1046/j.1469-0691.2001.00204.x,Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobactet species,Lee,2003,1
10.1038/psp.2012.4,"Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development",Mould,2012,1
10.1016/0009-9236(95)90260-0,Intention-to-treat analysis and the goals of clinical trials*,Sheiner,2004,1
10.1093/biomet/63.3.581,Inference and missing data,RUBIN,2007,1
10.1056/nejmoa1101549,Mortality after Fluid Bolus in African Children with Severe Infection,Maitland,2011,1
10.1371/journal.pmed.0010018,Assessment of Volume Depletion in Children with Malaria,Planche,2004,1
10.1016/0035-9203(94)90504-5,Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance,Krishna,2004,1
10.1111/j.1365-2265.1990.tb03911.x,Glucose Metabolism In Quinine-Treated Patients With Uncomplicated Falciparum Malaria,Davis,2008,1
10.1016/0002-9343(74)90848-1,Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency,Willerson,2004,1
10.1016/s0140-6736(69)90637-0,PLASMA-CATECHOLAMINES AFTER CARDIAC INFARCTION,Mcdonald,2003,1
10.1016/j.jcrc.2018.08.026,Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion,Carrié,2018,1
10.1097/ta.0000000000001387,Identifying augmented renal clearance in trauma patients,Barletta,2017,1
10.1093/cid/cit582,Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia,Falcone,2013,1
10.1128/aac.44.11.2948-2953.2000,Once-Daily Dosing in Dogs Optimizes Daptomycin Safety,Oleson,2002,1
10.1016/j.ijantimicag.2012.02.010,What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance,Udy,2012,1
10.1177/0310057x0903700123,You Only Find what you Look for: The Importance of High Creatinine Clearance in the Critically Ill,Udy,2019,1
10.1007/s00134-007-0745-5,Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study,Herrera-Gutiérrez,2007,1
10.1038/ki.1985.101,Course of acute renal failure studied by a model of creatinine kinetics,Mark Moran,2007,1
10.1016/0002-9343(82)90475-2,Glomerular and tubular function in non-oliguric acute renal failure,Myers,2004,1
10.1016/0002-9343(75)90124-2,Effect of intrarenal furosemide on renal function and intrarenal hemodynamics in acute renal failure,Epstein,2004,1
10.1016/s0002-9343(70)80073-0,Renal failure in the patient with cirrhosis,Epstein,2006,1
